isoantigens Leb-6 and Leb-8 in the glycosphingolipid fraction derived from gastric adenocarcinoma of B blood-group patients. Siddiqui et al. (11) isolated Leb-6 glycosphingolipid from cancer tissues but not from normal tissues. Hattori et al. (12) showed that Lea-active glycolipid levels were higher but Leb levels were lower in cancer tissues than in uninvolved tissue.
We report here the use of monoclonal antibodies in the biochemical characterization of the Lea-and Leb-active glycosphingolipid and glycoprotein antigens from the same cells. We found that Lea and Leb glycolipid antigens coexist in tumor cells, which is consistent with the results of chemical studies (8) and with observations based on immunoperoxidase techniques (13) . The distribution of the Lea and Leb activities in the glycoprotein fraction corresponded well with that in glycolipids.
MATERIALS AND METHODS
Monoclonal Antibodies. Lea-and Le"-specific antibodies CO-51. 4 and CO-43.1, respectively, were produced by the hybridomas obtained after immunization of mice with colon carcinoma1 cell lines SW1116 and SW1222, respectively (37) . P3 x 63Ag8 myeloma supernatant was psed as a control. An anti-A blood group antibody, obtained from C. Civin (Johns Hopkins University), was used in one set ofexperiments (38) .
Cells and Tissues. The following carcinoma cell lines were analyzed for expression of Lea and Leb antigens: one gastric (KATO-11), two pancreatic (CAPAN-2 and CH), seven colon (SW1116, SW948, SW1222, SW620, SW403, SW1345, and SW48), and one rectal (SW707) (39) . Normal colon and colorectal adenocarcinoma specimens were obtained from the Fox Chase Cancer Center in Philadelphia.
Detection of Antigen Expression. Reactivity of the monoclonal antibodies that detect Lewis antigens with human gastrointestinal tumor cells was evaluated in radioimmuno~assay (RIA) and in a mixed hemadsorption assay (MHA) as described (14) .
Preparation DNase I (Sigma) in Eagle's minimal essential medium at 370C for 30 min, Supernatants were collected after incubation and the procedure was repeated twice. Supernatants were centrifuged and the cell pellet was washed with Dulbecco's phosphate-buffered saline. Normal colon mucosa and colon carcinoma cell lines were labeled with 125I by the lactoperoxidase method as described (18) . Radiolabeled cells were solubilized with 50 mM Tris Cl buffer (pH 7.0) containing 150 mM NaCI, 5 mM EDTA, 0.5% Nonidet P-40, and 0.2 mM phenylmethylsulfonyl fluoride for 30 min at room temperature and centrifuged at 100,000 x g for 1 hr. Immunoprecipitation and sequential immunoprecipitation procedures were done as described (19) . NaDodSO4/PAGE was in a 10% polyacrylamide gel under the conditions described by Laemmli et al. (20) and two-dimensional gel electrophoresis was as described by O'Farrell et al. (21) . Dried gels were autoradiographed with Kodak film and DuPont intensifying screens.
Abbreviations: Lea, Lewis a antigen; Leb, Lewis b antigen; MHA, mixed hemadsorption assay.
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Solid-Phase RIA. Solid-phase RIAs were performed with purified non-acid lipid fractions from normal colon mucosa, colon tumors, and carcinoma cell lines, according to the procedure of Brockhaus et al. (22) .
Chromatogram Binding Assay. Non-acid lipid fractions were analyzed according to the procedure described by Hansson et al. (17) .
RESULTS
Expression of Cell-Surface Antigens. Table 1 Fig. 1 . The non-acid lipid fractions from four normal colon samples were reactive with the anti-Lea (Fig. 1A) but not with the anti-Leb antibody (Fig. 1B) , in accord with the results in solid-phase RIA (Table 2 ). All fractions tested in the chromatogram binding assay showed a major band corresponding to (Fig. 1A) . The multiple, closely migrating bands at the Lea-5 region probably reflect ceramide heterogeneity. One minor, slowly migrating band corresponds to Lea-7. Slow-moving bands were not detected in glycolipids from three out of four colon tumors and most of the gastrointestinal-tract carcinoma cell lines. Lea-active glycolipids from colon tumor sample CT-1 and from pancreatic carcinoma cell line CH showed the presence of an (Fig. 1B) . The fractions derived from a fresh colon adenocarcinoma (CT-1) and from the KATO-III, CH, SW707, SW1116, and SW948 cell lines revealed faint, slow-moving bands of about eight sugars. Rectal carcinoma cell line SW707 and colon carcinoma cell line SW948 also showed the presence of Leb-active structures of about 15 or more sugars, since they did not migrate on the plate.
Electrophoretic Profile of the Lea and Leb Glycoprotein
Immunoprecipitates. Fig. 2 tein was immunoprecipitated from cell line SW948 (Fig. 2) . The SW620 colon carcinoma cell line was negative for both antigens, in accord with the results obtained for glycolipids ( Fig. 1 A and B) .
The glycoproteins isolated from most of the gastrointestinal tumor cell lines had similar apparent Mrs in NaDodSO4/ PAGE. The tumor cell lines revealed a Mr 150,000 component and a very high Mr component(s) that does not enter the separating gel. The glycoproteins from the SW1116 cell line were resolved as three bands (Mr 75,000, 80,000, and 85,000) when precipitated with either antibody (Fig. 2, SW1116 lanes  2 and 3) .
Glycoproteins bearing Lea and Leb structures isolated from the same cells appear to have the same electrophoretic mobility.
Identification of Lea and Leb Glycoproteins from SW1116 Cells by Two-Dimensional Gel Electrophoresis. The surface membrane proteins from 125I-labeled SW1116 cells were immunoprecipitated with anti-Lea and -Leb antibodies and subjected to two-dimensional gel electrophoresis. Virtually identical patterns were observed (Fig. 3) . The protein spots corresponded to Mrs again in the range 75,000-85,000 and to pIs of 5.0-6.5.
The Lea-active glycoproteins from normal colon (not shown) migrated in two-dimensional gel electrophoresis as a single, strongly acidic protein of Mr 150,000 (see also Fig. 2) and pl 3.2. The Leb-active glycoprotein antigen was again absent.
Sequential Immunoprecipitation of Glycoprotein(s) with Le' and Leb Activity. Sequential immunoprecipitation analysis was performed to determine whether the Lea and Leb determinants are on the same molecule, which would explain the migration of the protein spots to identical Mr positions. SW1116 cells were found to have an A blood group phenotype in solid-phase RIA (data not shown). In the present experiments, an anti-A blood group monoclonal antibody was included together with anti-Lea and anti-Leb monoclonal antibodies. After immunoprecipitation of Lea-active glycoprotein from the cell lysate, precipitation with the anti-Leb antibody yielded no radioactive band (Fig. 4) . When the antibodies were used in the reverse order, no radioactive band was obtained with anti-Lea. These data indicate that the Lea and Leb carbohydrate determinants are associated with the same protein cores. The blood group A determinant is probably also associated with the same proteins as Lea and Leb, since the anti-A blood group antibody immunoprecipitated almost no material when preceded by anti-Lea or anti-Leb immunoprecipitation (Fig. 4) . The second precipitation also gave no bands when immunoprecipitation with anti-A blood group antibody was followed by anti-Lea or anti-Leb precipitation. Antibodies CO-51.4, CO-43.1, and aA are directed against Lea, Leb, and A blood group antigens, respectively. All lysates were absorbed with the first antibody and immunoprecipitated with the second antibody (sequence indicated by arrow) as described (18) .
results in biosynthesis of the Leb associated with colon adenocarcinoma. The coexistence of glycolipid forms of both Lea and Leb and not of Le-active glycoprotein in the gastrointestinal tumor cell lines tested indicates that the attachment of the Le-active oligosaccharides to a ceramide and the protein core proceeds by two independent enzymatic pathways. The core polypeptide for Lea, Leb, and the blood group A oligosaccharide haptens is the same, as demonstrated by sequential immunoprecipitation.
The availability of monoclonal antibodies specific for Lewis and other blood-group antigens has enabled elucidation of their long-debated chemical nature. We have shown that the oligosaccharide haptens of Lea and Leb phenotypes are expressed on both glycolipid and glycoprotein moieties in gastrointestinal tumors. The expression, distribution, and involvement of blood-group antigens in the process of malignancy can now be studied further using monoclonal reagents. Some relationship between Leb and blood-group antigens of the ABO system can be drawn in this respect. ABO antigens are not detectable in normal mucosa of distal colon but were found in adenocarcinomas of this region by immunocytochemical methods (32, 33, 38) . Also, ABO and Lewis antigens appear at 8 weeks of gestation and are suppressed after birth (34) (35) (36) . Their reexpression in tumors of distal colon mimics the situation in embryonal life; thus Leb and ABO substances in tumors of this part of the colon may be considered to be of oncodevelopmental type.
DISCUSSION
The Lea and Leb glycolipid antigens were coexpressed in human adenocarcinoma tissues and tumor cell lines in 10 out of 14 cases as detected by solid-phase RIA. The original Lewis phenotype and secretor status of the patients were not available. Leb was expressed in each of the four colon tumor samples but not in the normal colon mucosa obtained from the same respective patients.
Ernst et al. (13) detected Leb in 73% of distal colon carcinomas by using an immunoperoxidase staining technique. Normal tissue from the distal colon expressed only Lea. Based on those results, we assume that the normal colon and colon tumor samples used in the present study derived from distal colon. All gastrointestinal tumor cell lines that were positive for Lewis antigens coexpressed both Lea and Leb, in accord with previous observations (7, 8, 13) .
In the chromatogram binding assay of the Lea-active glycolipids, the slow-moving bands representing the extended structures of the antigen were absent in three out of four colon tumor samples, whereas their normal counterparts contained these structures. Five out of seven ofthe tumor cell lines also lacked these extended structures. These findings are consistent with the reported diminished capacity of some transformed cells (23) (24) (25) and tumors (26, 27) to extend the carbohydrate chains of their glycolipids. The suppression of specific glycosyltransferases might account for the incomplete synthesis of higher glycolipids (28) (29) (30) .
The Leb blood group activity in tissues is under the control of the Se (secretor) gene and is a gene-interaction product of Se and the Lewis gene Le (31) . The expression of Lea but not Leb in normal colon tissue suggests that the H gene, which encodes an Leb precursor and is controlled by the Se gene, is inactive, while the Le gene remains able to encode Lea. It is possible that in individuals who are genotypically either Lele or LeLe, the transformation process activates a regulatory function of the Se gene over the H gene or directly induces the H-encoded (al-*4)fucosyltransferase. The (al-*4)fucosyltransferase, which acts on a lacto-N-tetraosylceramide resulting in H type I substance, is influenced by Se or is induced directly in the process of malignancy and
